ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Theron
|
11K |
3.7M |
14 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
11K
|
3.7M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Theron
|
265 |
108K |
27 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
265
|
108K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Jane Bell Appointed Chair of Audit and Risk Committee
|
|
Theron
|
65 |
25K |
9 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
65
|
25K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Questions for MSB Management:
|
|
Theron
|
106 |
28K |
7 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
106
|
28K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Jane Bell Appointed Chair of Audit and Risk Committee
|
|
Theron
|
65 |
25K |
4 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
65
|
25K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Theron
|
5.9K |
2.9M |
10 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
5.9K
|
2.9M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Theron
|
574 |
203K |
8 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
574
|
203K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Theron
|
574 |
203K |
7 |
24/09/23 |
24/09/23 |
ASX - By Stock
|
574
|
203K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Theron
|
574 |
203K |
3 |
23/09/23 |
23/09/23 |
ASX - By Stock
|
574
|
203K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Theron
|
574 |
203K |
11 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
203K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Theron
|
574 |
203K |
39 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
203K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Theron
|
3.4K |
1.2M |
7 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Theron
|
18K |
7.1M |
15 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
18K
|
7.1M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Theron
|
18K |
7.1M |
40 |
17/09/23 |
17/09/23 |
ASX - By Stock
|
18K
|
7.1M
|
40
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Theron
|
18K |
7.1M |
17 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
18K
|
7.1M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Theron
|
11K |
3.7M |
3 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
11K
|
3.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Theron
|
11K |
3.7M |
5 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
11K
|
3.7M
|
5
|
|
ASX - By Stock
|
AMA |
Re:
Ann: Completion of Placement and Institutional Entitlement Offer
|
|
Theron
|
36 |
14K |
3 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
36
|
14K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Theron
|
3.4K |
1.2M |
6 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Theron
|
11K |
3.7M |
9 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
11K
|
3.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Theron
|
11K |
3.7M |
0 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
11K
|
3.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Theron
|
3.4K |
1.2M |
7 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Theron
|
3.4K |
1.2M |
4 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Theron
|
3.4K |
1.2M |
15 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Theron
|
11K |
3.7M |
14 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
11K
|
3.7M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Theron
|
913 |
300K |
21 |
20/08/23 |
20/08/23 |
ASX - By Stock
|
913
|
300K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
rexlemestrocel-L in the treatment of chronic low back pain (CLBP)
|
|
Theron
|
24 |
7.5K |
3 |
12/08/23 |
12/08/23 |
ASX - By Stock
|
24
|
7.5K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
rexlemestrocel-L in the treatment of chronic low back pain (CLBP)
|
|
Theron
|
24 |
7.5K |
11 |
12/08/23 |
12/08/23 |
ASX - By Stock
|
24
|
7.5K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
The FDA is a corrupt organization.
|
|
Theron
|
155 |
59K |
7 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
155
|
59K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Huge uplift predicted for Mesoblast
|
|
Theron
|
82 |
30K |
24 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
82
|
30K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Huge uplift predicted for Mesoblast
|
|
Theron
|
82 |
30K |
9 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
82
|
30K
|
9
|
|
ASX - By Stock
|
BKL |
Re:
Ann: F18 Half Year Results Announcement
|
|
Theron
|
8 |
10K |
7 |
22/02/18 |
22/02/18 |
ASX - By Stock
|
8
|
10K
|
7
|
|
ASX - By Stock
|
BKL |
Will ASIC investigate
|
|
Theron
|
0 |
858 |
0 |
11/01/18 |
11/01/18 |
ASX - By Stock
|
0
|
858
|
0
|
|
ASX - By Stock
|
RHC |
Re:
Charlie Aitken shorting RHC
|
|
Theron
|
152 |
92K |
4 |
05/10/17 |
05/10/17 |
ASX - By Stock
|
152
|
92K
|
4
|
|
ASX - By Stock
|
RHC |
Re:
Charlie Aitken shorting RHC
|
|
Theron
|
152 |
92K |
3 |
20/09/17 |
20/09/17 |
ASX - By Stock
|
152
|
92K
|
3
|
|
ASX - By Stock
|
RHC |
Re:
Ann: Presentation - FY2017 Financial Results Briefing
|
|
Theron
|
69 |
37K |
5 |
30/08/17 |
30/08/17 |
ASX - By Stock
|
69
|
37K
|
5
|
|
ASX - By Stock
|
SRX |
Re:
Sirtex faces class action
|
|
Theron
|
46 |
14K |
2 |
02/08/17 |
02/08/17 |
ASX - By Stock
|
46
|
14K
|
2
|
|
ASX - By Stock
|
SRX |
Re:
Ann: Ceasing to be a substantial holder
|
|
Theron
|
7 |
3.1K |
2 |
06/07/17 |
06/07/17 |
ASX - By Stock
|
7
|
3.1K
|
2
|
|
ASX - By Stock
|
SRX |
Re:
Upgraded to a buy
|
|
Theron
|
200 |
75K |
1 |
26/05/17 |
26/05/17 |
ASX - By Stock
|
200
|
75K
|
1
|
|
ASX - By Stock
|
SRX |
Re:
Upgraded to a buy
|
|
Theron
|
200 |
75K |
1 |
23/05/17 |
23/05/17 |
ASX - By Stock
|
200
|
75K
|
1
|
|
ASX - By Stock
|
RHC |
Re:
Ann: Dividend/Distribution - RHC
|
|
Theron
|
63 |
26K |
2 |
16/03/17 |
16/03/17 |
ASX - By Stock
|
63
|
26K
|
2
|
|
ASX - By Stock
|
BKL |
Re:
Ann: Change of Director's Interest Notice
|
|
Theron
|
12 |
5.7K |
1 |
23/02/17 |
23/02/17 |
ASX - By Stock
|
12
|
5.7K
|
1
|
|
ASX - By Stock
|
BKL |
Re:
Very quiet in here.
|
|
Theron
|
26 |
11K |
1 |
21/02/17 |
21/02/17 |
ASX - By Stock
|
26
|
11K
|
1
|
|
ASX - By Stock
|
FMG |
Re:
Iron Ore Price
|
|
Theron
|
20K |
5.5M |
3 |
10/01/17 |
10/01/17 |
ASX - By Stock
|
20K
|
5.5M
|
3
|
|
ASX - By Stock
|
FMG |
Re:
Peartart/Franky's dividend poll
|
|
Theron
|
80 |
15K |
3 |
08/01/17 |
08/01/17 |
ASX - By Stock
|
80
|
15K
|
3
|
|
ASX - By Stock
|
FMG |
Re:
Iron Ore Price
|
|
Theron
|
20K |
5.5M |
3 |
04/01/17 |
04/01/17 |
ASX - By Stock
|
20K
|
5.5M
|
3
|
|
ASX - By Stock
|
FMG |
Re:
Iron Ore Price
|
|
Theron
|
20K |
5.5M |
0 |
22/12/16 |
22/12/16 |
ASX - By Stock
|
20K
|
5.5M
|
0
|
|
ASX - By Stock
|
FMG |
FMG ripe for another debt repayment
|
|
Theron
|
0 |
334 |
1 |
15/12/16 |
15/12/16 |
ASX - By Stock
|
0
|
334
|
1
|
|
ASX - By Stock
|
FMG |
Re:
Iron Ore Price
|
|
Theron
|
20K |
5.5M |
1 |
15/12/16 |
15/12/16 |
ASX - By Stock
|
20K
|
5.5M
|
1
|
|
ASX - By Stock
|
SRX |
Re:
Shareholder Activism
|
|
Theron
|
11 |
4.6K |
1 |
14/12/16 |
14/12/16 |
ASX - By Stock
|
11
|
4.6K
|
1
|
|